Picture of Q32 Bio logo

QTTB — Q32 Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Brief: Homology Medicines Announces Presentations On Design Of Ongoing Gene Editing And Gene Therapy Trials For Pku And Hunter Syndrome At Acmg Annual Clinical Genetics Meeting

March 15 (Reuters) - Homology Medicines Inc  FIXX.O :
    * HOMOLOGY MEDICINES ANNOUNCES PRESENTATIONS ON DESIGN OF
ONGOING
GENE EDITING AND GENE THERAPY TRIALS FOR PKU AND HUNTER SYNDROME
AT ACMG ANNUAL CLINICAL GENETICS MEETING

Source text for Eikon:  ID:nGNXbRSGCw 
Further company coverage:  FIXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Q32 Bio

See all news